Related Experiment Video
Updated: Jun 3, 2026

13:29
Electric and Magnetic Field Devices for Stimulation of Biological Tissues
Published on: May 15, 2021
Chondroprotective effects of pulsed electromagnetic fields on human cartilage explants
Alessia Ongaro1, Agnese Pellati, Federica Francesca Masieri
1Department of Morphology and Embryology, University of Ferrara, Ferrara, Italy. ngrlss@unife.it
Bioelectromagnetics
|March 18, 2011
Summary
Pulsed electromagnetic fields (PEMFs) and IGF-I enhance proteoglycan synthesis in osteoarthritis cartilage. These treatments offer chondroprotective effects, counteracting the damaging IL-1β in early-stage osteoarthritis.
Area of Science:
- Orthopedics and Regenerative Medicine
- Biomaterials Science
- Cellular and Molecular Biology
Background:
- Osteoarthritis (OA) is characterized by cartilage degradation.
- Proteoglycan (PG) metabolism is crucial for cartilage health.
- Interleukin-1 beta (IL-1β) is a key catabolic mediator in OA.
Purpose of the Study:
- To investigate the effects of pulsed electromagnetic fields (PEMFs) and Insulin-like Growth Factor-I (IGF-I) on human articular cartilage explants in osteoarthritis.
- To evaluate the impact of PEMF and IGF-I on proteoglycan (PG) synthesis and release.
- To determine the chondroprotective potential of PEMF and IGF-I against IL-1β-induced catabolism.
Main Methods:
- Human articular cartilage explants from OA patients (grades I and III) were cultured.
- Explants were treated with PEMF (1.5 mT, 75 Hz), IGF-I, or a combination, with or without IL-1β.
- Proteoglycan synthesis was measured using 35S-sulfate incorporation.
Main Results:
- Both PEMF and IGF-I significantly increased PG synthesis in OA grade I and III explants.
- PEMF and IGF-I counteracted the inhibitory effects of IL-1β on PG synthesis.
- Combined PEMF and IGF-I exposure demonstrated additive anabolic effects.
Conclusions:
- PEMF and IGF-I augment anabolic activities and PG synthesis in human OA cartilage.
- These agents exhibit chondroprotective effects by counteracting IL-1β's catabolic activity.
- PEMF and IGF-I show promise for managing early-stage osteoarthritis.
